Ryan Florek Email & Phone Number

Fountain Hills, AZ, US

Payson, Arizona, US

New York, New York, US

• Initiated strategies and tactics with assigned IDNs and aggregations to maintain current business, drive growth through GPO committed agreements, and analyzed opportunities for additional programs.
• Collaborated with local Surgical, Sterile Injectable, and Biosimilar teams to support the Pfizer Essential Health portfolio.
• Identified and corrected a rebate program that was administered outside of the contract language provided. The contract reporting requirements for both the customer and Pfizer were appropriately addressed and corrected.
• HSAE team lead for the development of Beacon as the platform transitioned from Achieve 3D. Provided the technology team with insights that would generate stronger reports for the analysis of market share levels at the.
• Selected as the team representative to support the eDART initiative where I was able to advance the need for improved data reporting and analysis of reports. My recommendations aligned to the business needs identified.
• Responsible for the executive relationship at IDN’s including: Catholic Health Initiatives, Centura Health, University of Colorado Health, Sisters of Charity of Leavenworth, Integris Health, HealthONE, St. John’s.

• Established a contract portfolio from scratch by negotiating and executing 8 group purchasing organization (GPO) and institutional agreements with leading organizations within certain target markets.
• Created and implemented a commitment program with one of the largest oncology groups in the country. Working with internal and external partners, market share within the account grew from 37% to 81% during my oversight.
• Grew contracted sales in the portfolio to greater than $100 million annually, with continual growth month over month.
• Focused on oncology and institutional accounts, successfully increased overall “non-retail” market share in the product class from 25% to over 86% during a two year period, while overall market share topped out around.
• Responsible for the breadth of contract management activities to support the portfolio, including:
• Contract negotiation, creation, and modification of GPO contracts; pricing and contractual amendments; contract administration including working with our 3PL to implement contract and product changes; class of trade.

New York, New York, US

• Lead for the Strategy team supporting 30+ new product launches and the Go-To-Market process for all account groups and types including: GPO contracts, wholesaler contracts, private label, list prices, and other.
• Continually provided communications to the field by reviewing market conditions and providing contract opportunities.
• Monitored effectiveness of contracting strategies, making recommendations to improve utilization pull through, internal profitability, contract position, or additional commitments as part of a continual portfolio review.
• Challenged the status –quo on several historical contracting strategies, focusing efforts on influencing pharmacy purchasers, IDN representatives, wholesalers, alternate care channels, and group purchasing organizations.
• Significantly contributed to the enhanced contract terms and conditions template, leading to more favorable terms, greater flexibility within the agreement, improved product positioning, and reduced financial risks to.

Alpharetta, GA, US

• Managed vendor relationships and negotiated terms and pricing for 81 of the most complex contracts with a focus on generic injectable pharmaceutical agreements containing over 600 chargebacks/contracts and commitment.
• Completed a full portfolio bid roll and established the generic bid roll analytical tool which provided full scale analysis of $400 million in customer purchases. The tool allowed dynamic analysis and optimization of.
• Presented portfolio recommendations to the Pharmacy Advisory Committee and the Executive Steering Committee.
• Provided contract compliance level reporting resulting in price level optimizations for customers and competitive analysis for suppliers.
• Established meetings for medical liaisons and clinical directors to review clinical studies, product benefits, and risks for both clinical and financial opportunities.
• Served as the operational expert for contracting services by launching the pharmacy OnRamp community, further publicizing the bulletins and contract news, reviewing contract administration’s process workflows.

Dallas, US

Dallas, US

• Negotiated and managed over $250 million in laboratory contracts containing capital equipment, reagents, consumables, and service.
• Increased overall lab contract portfolio by 31% in 18 months from $388 million to over $510 million in an otherwise flat market. This portfolio growth resulted in an additional $3.6 million in revenue per year for the.
• Saved customers $9.4 million in 2007 by constructing pricing strategies based on RFI and RFP responses.
• Developed monthly presentations for management, advisory committees, and steering committees by researching market conditions, compiling and summarizing data, and analyzing potential outcomes for clients.
• Created several letters of commitment (LOC’s) that addressed the needs of suppliers, customers and Broadlane.

US

• Performed financial analyses of brand, generic, and specialty drug contracts totaling over $20 billion in sales and presented financial results and recommendations to management for final signoff and approval.
• Trained analysts on differences in contract terms of the discount model versus the GPO model.
• Created templates to assist with the analysis of changes to terms, discounts, and conditions of proposed and current contracts. The creation of these flexible, cross-functional templates allowed several groups within.
• Developed quarterly and ad hoc reports to internal business groups that included discounts, marketshares, and pricing discrepancies for Caremark’s contracted products. These reports provided management and negotiators.

US

• Established extensive knowledge of the Caremark’s adjudication engine and suggested benefit plan improvements to the eligibility, drug file, administration, and implementation teams.
• Analyzed new client contracts, proposed plan designs, and implemented drug coverage strategies in all of the 2004 pre implementation audits for accuracy, consistency, and client intent.
• Performed highly detailed client contract analyses of several million individual claims for special project audits. Findings from the analyses rectified client plan changes and identified reoccurring issues within the.
• Communicated with contract managers the results of client audits and provided recommendations for changes to exhibits, terms, and language within the client contracts.
• Participated in pre-implementation calls with consultants and provided feedback to the implementations team with regards to optimal benefit plan set up.

Bachelor Of Business Administration (Bba), Finance, Investments, Insurance

Education record